1. Home
  2. PHVS vs HLMN Comparison

PHVS vs HLMN Comparison

Compare PHVS & HLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • HLMN
  • Stock Information
  • Founded
  • PHVS 2015
  • HLMN 1964
  • Country
  • PHVS Switzerland
  • HLMN United States
  • Employees
  • PHVS N/A
  • HLMN 3886
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • HLMN Industrial Machinery/Components
  • Sector
  • PHVS Health Care
  • HLMN Consumer Discretionary
  • Exchange
  • PHVS Nasdaq
  • HLMN Nasdaq
  • Market Cap
  • PHVS 1.6B
  • HLMN 1.9B
  • IPO Year
  • PHVS 2021
  • HLMN N/A
  • Fundamental
  • Price
  • PHVS $22.08
  • HLMN $9.44
  • Analyst Decision
  • PHVS Buy
  • HLMN Buy
  • Analyst Count
  • PHVS 6
  • HLMN 6
  • Target Price
  • PHVS $36.50
  • HLMN $12.20
  • AVG Volume (30 Days)
  • PHVS 217.1K
  • HLMN 886.9K
  • Earning Date
  • PHVS 11-12-2025
  • HLMN 11-04-2025
  • Dividend Yield
  • PHVS N/A
  • HLMN N/A
  • EPS Growth
  • PHVS N/A
  • HLMN 258.10
  • EPS
  • PHVS N/A
  • HLMN 0.11
  • Revenue
  • PHVS N/A
  • HLMN $1,505,004,000.00
  • Revenue This Year
  • PHVS N/A
  • HLMN $8.11
  • Revenue Next Year
  • PHVS N/A
  • HLMN $7.85
  • P/E Ratio
  • PHVS N/A
  • HLMN $87.77
  • Revenue Growth
  • PHVS N/A
  • HLMN 1.93
  • 52 Week Low
  • PHVS $11.51
  • HLMN $6.55
  • 52 Week High
  • PHVS $26.33
  • HLMN $12.08
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 49.23
  • HLMN 53.79
  • Support Level
  • PHVS $22.38
  • HLMN $9.48
  • Resistance Level
  • PHVS $23.64
  • HLMN $9.86
  • Average True Range (ATR)
  • PHVS 1.28
  • HLMN 0.27
  • MACD
  • PHVS 0.04
  • HLMN 0.03
  • Stochastic Oscillator
  • PHVS 61.27
  • HLMN 68.75

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S., Canada and Mexico.

Share on Social Networks: